Brief: Imricor Medical Systems Says Receives Approval From Saudi Food And Drug Authority
11/01/2024 01:00
Jan 11 (Reuters) - Imricor Medical Systems Inc IMR.AX :
* IMRICOR RECEIVES APPROVAL FROM SAUDI FOOD AND DRUG
AUTHORITY
* RECEIVED MEDICAL DEVICE MARKETING AUTHORIZATION (MDMA)
FROM
SAUDI FOOD & DRUG AUTHORITY
Source text for Eikon: ID:nASX2n9LYl
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion